United Therapeutics Corp Sustainability Reports
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases, specifically pulmonary arterial hypertension. It is also actively developing technologies designed to expand the availability of transplantable organs.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5299005C4HZL4UWROC14
FIGI: BBG001S8RV10
8 reports from 2019 to 2024
- United Therapeutics Corp 2024 Reporting Indexes
- United Therapeutics Corp 2024 Corporate Responsibility and Public Benefit Report
- United Therapeutics Corp 2023 Form 10-K
- United Therapeutics Corp 2023 Corporate Responsibility and Public Benefit Report
- United Therapeutics Corp 2022 Corporate Responsibility and Public Benefit Report